Teleflex wins FDA clearance for mask; Torax ramps up GERD sales;

@FierceMedDev: Dx startup On-Q-ity shuts down. DxExtra story | Follow @FierceMedDev

@MarkHFierce: Altura Medical drew in $6M in new financing for AAA stent graft develpment, according to a regulatory filing. Story | Follow @MarkHFierce

 @DamianFierce: Boston Scientific is launching a new, FDA-approved neuromodulation device for chronic back pain. Article | Follow @DamianFierce

> Torax Medical in Minnesota is gaining traction with its new Linx device, a magnetic bracelet implanted at the base of the throat to treat severe acid reflux. Story

> Teleflex ($TFX) obtained 510(k) clearance for a new device/mask designed to help clinicians reduce their exposure to hazardous waste anesthetic gases. Release

> Amendia, a specialty medical-device manufacturer, plans to invest up to $50 million to help a biomedical spinoff bring to market implant technology designed to stimulate bone regrowth. Story (subs. req.)

> TeVido BioDevices in Texas is developing a 3D inkjet printer that would make a customized breast implant. Story

> Brightstone Venture Capital in Minnesota is on the hunt, in part, for new life sciences investments. Story (subs. required)

> Diagnostics company Veracyte has appointed Shelly Guyer, a veteran of iRhythm Technologies, to be its next CFO. Release

Biotech News

@FierceBiotech: Firm ranks top 5 biotech deals in evolving pharma R&D landscape. Report | Follow @FierceBiotech

@JohnCFierce: Another thought on $GSK: If it gets over tox issue, drisapersen is probably headed for approval, barring a nasty efficacy surprise in Ph3. | Follow @JohnCFierce.

@RyanMFierce: Just heard from ex-FDA CIO Eric Perakslis. We'll have more on his next move soon, hopefully. News on his departure: Story | Follow @RyanMFierce

> Firm ranks top 5 biotech deals in evolving pharma R&D landscape. Report

> Boehringer Ingelheim fuels gene therapy startup focused on eye diseases. Article

> GlaxoSmithKline measures 38-meter leap over placebo in Duchenne walking test. News

Pharma News

@FiercePharma: More layoffs for $LLY: Eli Lilly to cut 100s of sales people in neuroscience, CV and men's health. Report | Follow @FiercePharma

@EricPFierce: C'est la vie. Sanofi finds the politics of downsizing in France a war of attrition. Report | Follow @EricPFierce

> Bristol-Myers, Lilly expand biologics operations. More

> Elan investors approve share buyback but still must decide on buyout. Story

> Roche CEO says no need to buy out Japanese subsidiary Chugai. Item

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.